According to IMARC Group’s latest research report, titled “Vascular Closure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” presents a comprehensive analysis of the industry, covering vascular closure devices market share, statistics size, trends, demand, and growth prospects. The report also provides competitor and regional analysis and showcases the contemporary advancements in the global market.
How big is the Vascular Closure Devices Market?
The global vascular closure devices market size reached US$ 1.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
What are Vascular Closure Devices?
Vascular closure devices (VCDs) represent the medical devices used to achieve hemostasis of the tiny hole in the artery after the cardiovascular procedure of endovascular surgery requiring a catheterization. Cardiovascular processes demanding catheterization include diagnostic procedures that aid in diagnosing diseased blood vessels and interventional methods, such as angioplasty, the placement of coronary thrombectomy, and a stent. During such processes, a small incision is created in the groin area, and a gap is made in the femoral artery to gain access. This void is referred to as the access or puncture site. At the completion of the procedure, the hole needs to be closed. Metal clip- and suture-based VCDs reduce the time to hemostasis compared to extrinsic (manual or mechanical) compression.
What are the Growth Prospects and Trends in the Vascular Closure Devices Market?
The rising number of approvals of these instruments, the high prevalence of heart-related diseases, and the increasing cases of obesity are among the primary factors driving the vascular closure devices market. Besides this, the launch of several policies by the government bodies to reimburse interventional radiology procedures and the escalating focus on effective blood loss management in patients during surgeries are further augmenting the market growth. Moreover, the growing popularity of vascular closure devices, as they quickly stop and reduce puncture site complications, seal the opening of an artery in surgery, coronary excision, and placement of a stent is also catalyzing the global market. Apart from this, the inflating medical expenditure of individuals, the expanding healthcare sector, and the elevating construction of hospitals and surgical centers are anticipated to propel the vascular closure devices market over the forecasted period.
Who are the key Players Operating in the Industry?
- Abbott Laboratories
- Cardiva Medical Inc. (Haemonetics Corporation)
- Cordis Corporation (Cardinal Health Inc.)
- ENDOCOR GmbH & Co. KG
- Merit Medical Systems Inc.
- Morris Innovative Inc.
- Teleflex Incorporated
- Terumo Medical Corporation (Terumo Corporation)
- Transluminal Technologies LLC
- Vasorum Ltd.
What is included in Market Segmentation?
The report has segmented the market into the following categories:
- Passive Approximators
- Collagen Plugs
- Sealant or Gel-Based Devices
- Compression-Assist Devices
- Active Approximators
- Suture-Based Devices
- Clip-Based Devices
- External Hemostatic Devices
- Femoral Access
- Radial Access
- Interventional Cardiology
- Interventional Radiology/Vascular Surgery
- Ambulatory Surgical Centers
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
visit home page https://cityoftips.com